The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Pharmaceuticals and Biopharmaceuticals AAIPharma Services Corp. Wilmington, NC Manufacturing locations: Charleston, SC and Wilmington, NC www.aaipharma.com (800) 575-4224 Contact: Rob Goshert rob.goshert@aaipharma.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical and clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, nonsterile, parenterals (small volume), peptides, powders (nonsterile), proteins, solid dose, solutions & suspensions, sterile, and sustained release. "This has been a period of building on AAIPharma's long history of providing the highest quality analytical testing, drug product development, and manufacturing services. Over the past year, AAIPharma has added a state-of-the-art technology center, more than doubled our solid dose manufacturing capacity, implemented new ERP and document management systems, moved to electronic lab notebooks, and will double our parenteral manufacturing capacity by year end. During this period our facilities also hosted very successful audits by the FDA, EMA, and DEA." — Patrick Walsh, CEO DRUG TYPE: Pharmaceuticals and Biopharmaceuticals AbbVie Contract Manufacturing North Chicago, IL Manufacturing locations: Germany, Ireland, Italy, Puerto Rico, and United States www.abbviecontractmfg.com (847) 938-8524 Contact: Lisa Wallerich lisa.wallerich@abbvie.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical and clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, fermentation, gels, injectables, liquids, nonsterile, OTC, parenterals (small volume), proteins, semisolids, soft gels, solid dose, sustained release, syringes (prefilled), and topicals. "AbbVie Contract Manufacturing is honored to be recognized globally for our expertise in quality, innovation, productivity and regulatory measures. This recognition affirms our commitment to our CMO partners and the patients who ultimately benefit from the therapies produced. At AbbVie, we share our partners' goals to combine innovative solutions and expertise in manufacturing to develop and deliver quality products that keep the patient at the center of our work." — Azita Saleki-Gerhardt, Ph.D., senior vice president, operations DRUG TYPE: Pharmaceuticals Aesica Pharmaceuticals Newcastle upon Tyne, England Manufacturing locations: Germany, Italy, and United Kingdom www.aesica-pharma.com 0191 2181969 Contact: Georgia Linscott georgia.linscott@aesica-pharma.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, lyophilized products, nonsterile, parenterals (large volume), parenterals (small volume), peptides, powders (nonsterile), powders (sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, sustained release, syringes (prefilled), and topicals. "We are delighted to have been recognized as a leader in the areas of quality, reliability, innovation, and productivity in order to have been awarded a 2013 CMO Leadership Award. The company remains focused on growth and we continue to increase our output and expand our global customer base." — Robert Hardy, CEO 32 The CMO Leadership Awards 2013